References
- USP drug release, U.S. Pharmacopoeia 23. U.S. Pharmacopeial Convention, Inc., Rockville, MD 1994; 1580–1583
- Dissolution test, Supplement I, Japanese Pharmacopoeia XII. English Version. Ministry of Health and Welfare, Tokyo 1993; 788–791
- Morimoto Y. Therapeutic Res. 1990; 11(3)662–667, (in Japanese)
- Shah V. P., Skelly J. P. Topical Drug Bioavailability, Bioequivalence. and Penetration, V. P. Shah, H. I. Maibach. Plenum Press, New York 1993; 107–116
- Shah V. P., Tymes N. W., Yamamoto L. A., Skelly J. P. Int. J. Pharm. 1986; 32: 243–250
- Shah V. P., Elkins J., Hanus J., Noorizadeh C., Skelly J. P. Pharm. Res. 1991; 8: 55–59
- Dibbern H. W., Wirbitzki E. Pharm. Ind. 1983; 45(10)985–990
- Bottari F., Colo G. D., Nannipieri E., Saettone M. F., Serafini M. F. J. Pharm. Sci. 1974; 63: 1779–1783
- Shah V. P., Tymes N. W., Skelly J. P. J. Controlled Release 1988; 7: 79–86
- Hatanaka T., Inuma M., Sugibayashi K., Morimoto Y. Chem. Pharm. Bull. 1990; 38: 3453–3459
- Shah V. P., Skelly J. P. Topical Drug Bioavailability, Bioequivalence. and Penetration, V. P. Shah, H. J. Maibach. Plenum Press, New York 1993; 359–366
- Hadgraft J., Lewis D., Beutner D., Wolff H. M. Int. J. Pharm. 1991; 73: 125–130